Cochlear Limited Stock Price
- 4 Narratives written by author
- 1 Comments on narratives written by author
- 77 Fair Values set on narratives written by author
COH Community Narratives
Cochlear’s Crossroads: Temporary Setback or Structural Shift?
Aging Population Will Spur Cochlear Implant Adoption Worldwide
Cloud And R&D Investment Will Pressure Margins While Long Term Hearing Demand Supports Stability
Aging Population Will Spur Cochlear Implant Adoption Worldwide
Cochlear’s newest implant is pitched as a smarter upgrade that could win over surgeons and keep the company ahead as more people seek treatment for hearing loss. But price pressure, slower demand in some regions, and higher costs to expand and modernize operations could make growth bumpier than it looks.Read more

Cloud And R&D Investment Will Pressure Margins While Long Term Hearing Demand Supports Stability
Catalysts About Cochlear Cochlear develops and manufactures hearing implant systems for people with severe to profound hearing loss. What are the underlying business or industry changes driving this perspective?Read more

Hearing Health Tailwinds And Cloud Capabilities Will Support Multi Year Earnings Expansion
Catalysts About Cochlear Cochlear develops and manufactures implantable hearing solutions for people with severe to profound hearing loss. What are the underlying business or industry changes driving this perspective?Read more

Trending Discussion
Recently Updated Narratives
Cochlear’s Crossroads: Temporary Setback or Structural Shift?
COH: Margin Resilience And Temporary Volume Weaknesses Will Support Future Upside
Cloud And R&D Investment Will Pressure Margins While Long Term Hearing Demand Supports Stability
Snowflake Analysis
Cochlear Limited Key Details
- 5.28
- 72.76%
- 14.77%
- 0.7%
About COH
- Founded
- 1981
- Employees
- 5500
- CEO
- Website
View website
Cochlear Limited provides implantable hearing solutions for children and adults worldwide. The company offers cochlear implant systems, sound processor upgrades, bone conduction systems, and other products. It also provides cochlear nucleus systems, including Nucleus sound processors, smart bimodal hearing solution, and Nucleus implants; cochlear Baha systems comprising Baha 6 max sound processor and Baha implant; and accessories, such as wireless devices and Nucleus water-safe accessories. The company was founded in 1981 and is headquartered in Sydney, Australia.
